US equities |
META $622.82 ▼-1.23% TSLA $402.04 ▲+2.66% MU $913.22 ▲+1.05% NVDA $215.84 ▼-0.07% SPCX $147.92 ▲+0.69% AMD $547.00 ▲+2.96% SNDK $1,287.00 ▲+2.50% INTC $92.09 ▲+1.79%
FinancialContent

Cencora, Inc. Common Stock (NY:COR)

327.50 -2.50 (-0.76%)
Delayed Quote Updated: 10:14 AM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Unveiling 4 Analyst Insights On Cencora ↗
 
Via Benzinga
News headline image
COR Stock Earnings: Cencora Beats EPS, Misses Revenue for Q2 2024 ↗
COR stock results show that Cencora beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Cencora Reports Fiscal 2024 Second Quarter Results
From Cencora
Via Business Wire
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today ↗
 
Via Benzinga
News headline image
3 High-Quality Stocks That Will Never Put You in the Red ↗
These quality stocks have real staying power and the ability to generate consistent profits and growth over the long haul. 
Via InvestorPlace
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today ↗
 
Via Benzinga
News headline image
$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Announces Leadership Succession Plan
From Cencora
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Critical Insights From Cencora Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Wednesday Is Your Last Chance To Buy Cencora Before The Dividend Payout ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today ↗
 
Via Benzinga
News headline image
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
News headline image
Why Walgreens Boots Alliance Stock Slumped 13.6% in January ↗
The pharmacy giant ended an era. 
Via The Motley Fool
News headline image
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
News headline image
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
From Walgreens Boots Alliance
Via Business Wire
News headline image
Peering Into Cencora's Recent Short Interest ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Cencora? ↗
 
Via Benzinga
News headline image
Cencora Closes $500 Million Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
From Cencora
Via Business Wire
News headline image
Drug Wholesale Firm Cencora Starts 2024 With Strong Growth, Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution ↗
Cencora reports Q1 2024 results with adjusted EPS at $3.28 and revenue of $72.3 billion. Explore the company's fiscal year 2024 guidance and growth projections. 
Via Benzinga
News headline image
Cencora Reports Fiscal 2024 First Quarter Results
From Cencora
Via Business Wire
News headline image
Earnings Scheduled For January 31, 2024 ↗
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
News headline image
Chart Of The Day: Cencora - Name Changed To Protect The Innocent? ↗
Cencora, Inc. sources and distributes pharmaceutical products. 
Via Talk Markets
News headline image
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference ↗
Cramer shared his insights during his attendance at JPMorgan's healthcare conference, 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >